MECCELLIS BIOTECH : revenue, balance sheet and financial ratios

MECCELLIS BIOTECH is a French company founded 14 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in LA ROCHELLE (17000), this company of category PME shows in 2017 a revenue of 1.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - MECCELLIS BIOTECH (SIREN 533383535)
Indicator 2022 2020 2019 2018 2017 2016 2015
Revenue N/C N/C N/C N/C 1 885 216 € 1 848 800 € 1 135 219 €
Net income -82 197 € -574 233 € -180 525 € -313 400 € 270 153 € 181 490 € 44 157 €
EBITDA N/C N/C N/C N/C 371 316 € 289 597 € 152 651 €
Net margin N/C N/C N/C N/C 14.3% 9.8% 3.9%

Revenue and income statement

In 2022, MECCELLIS BIOTECH records a net loss of 82 k€. This deficit will reduce equity on the balance sheet.

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-82 197 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 315%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 20%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

315.154%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

19.871%

Asset age ratio (2022) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

28.8%

Solvency indicators evolution
MECCELLIS BIOTECH

Sector positioning

Debt ratio
315.15 2022
2019
2020
2022
Q1: 5.37
Med: 27.47
Q3: 77.75
Watch

In 2022, the debt ratio of MECCELLIS BIOTECH (315.15) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
19.87% 2022
2019
2020
2022
Q1: 20.76%
Med: 45.8%
Q3: 65.06%
Average -16 pts over 3 years

In 2022, the financial autonomy of MECCELLIS BIOTECH (19.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 391.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

390.995

Liquidity indicators evolution
MECCELLIS BIOTECH

Sector positioning

Liquidity ratio
391.0 2022
2019
2020
2022
Q1: 159.69
Med: 240.02
Q3: 388.71
Excellent

In 2022, the liquidity ratio of MECCELLIS BIOTECH (391.00) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2022) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2022) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2022) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2022) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
MECCELLIS BIOTECH

Positioning of MECCELLIS BIOTECH in its sector

Comparison with sector Fabrication de matériel médico-chirurgical et dentaire

Similar companies (Fabrication de matériel médico-chirurgical et dentaire)

Compare MECCELLIS BIOTECH with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire

Frequently asked questions about MECCELLIS BIOTECH

What is the revenue of MECCELLIS BIOTECH ?

The revenue of MECCELLIS BIOTECH in 2017 is 1.9 M€.

Is MECCELLIS BIOTECH profitable?

MECCELLIS BIOTECH recorded a net loss in 2022.

Where is the headquarters of MECCELLIS BIOTECH ?

The headquarters of MECCELLIS BIOTECH is located in LA ROCHELLE (17000), in the department Charente-Maritime.

Where to find the tax return of MECCELLIS BIOTECH ?

The tax return of MECCELLIS BIOTECH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does MECCELLIS BIOTECH operate?

MECCELLIS BIOTECH operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.